BioCryst Pharma (BCRX) Announces Positive Interim Results from its APeX-1 Trial
Tweet Send to a Friend
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced results from an interim analysis of its Phase 2 APeX-1 trial in hereditary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
